U.S. flag

An official website of the United States government

NM_000132.4(F8):c.1834C>T (p.Arg612Cys) AND Familial aortopathy

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 8, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004540992.1

Allele description [Variation Report for NM_000132.4(F8):c.1834C>T (p.Arg612Cys)]

NM_000132.4(F8):c.1834C>T (p.Arg612Cys)

Gene:
F8:coagulation factor VIII [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq28
Genomic location:
Preferred name:
NM_000132.4(F8):c.1834C>T (p.Arg612Cys)
Other names:
F8, ARG593CYS; R593C; NM_000132.4(F8):c.1834C>T
HGVS:
  • NC_000023.11:g.154953961G>A
  • NG_011403.2:g.73763C>T
  • NM_000132.4:c.1834C>TMANE SELECT
  • NP_000123.1:p.Arg612Cys
  • NP_000123.1:p.Arg612Cys
  • LRG_555t1:c.1834C>T
  • LRG_555:g.73763C>T
  • LRG_555p1:p.Arg612Cys
  • NC_000023.10:g.154182236G>A
  • NG_011403.1:g.73763C>T
  • NM_000132.3:c.1834C>T
  • P00451:p.Arg612Cys
Protein change:
R612C; ARG593CYS
Links:
UniProtKB: P00451#VAR_001120; OMIM: 300841.0153; dbSNP: rs137852428
NCBI 1000 Genomes Browser:
rs137852428
Molecular consequence:
  • NM_000132.4:c.1834C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial aortopathy
Identifiers:
MedGen: CN078214

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005040802Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Mar 8, 2024)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Intensive peri-operative use of factor VIII and the Arg593-->Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A.

Eckhardt CL, Menke LA, van Ommen CH, van der Lee JH, Geskus RB, Kamphuisen PW, Peters M, Fijnvandraat K.

J Thromb Haemost. 2009 Jun;7(6):930-7. doi: 10.1111/j.1538-7836.2009.03357.x.

PubMed [citation]
PMID:
19548904

Detection of new mutations and molecular pathology of mild and moderate haemophilia A patients from southern Brazil.

Rosset C, Vieira IA, Sinigaglia M, Gorziza RP, Salzano FM, Bandinelli E.

Haemophilia. 2013 Sep;19(5):773-81. doi: 10.1111/hae.12172. Epub 2013 May 28.

PubMed [citation]
PMID:
23711237

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV005040802.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024